# BCD Bioscience, Inc. — Form D/A

BCD Bioscience, Inc. of DAVIS, CA, a company, filed a Form D amendment with the SEC on 2020-11-12. The offering totals $4.8M, of which $4.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-11-12
- Form: D/A
- Accession: 0001813229-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.8M
- Amount sold: $4.8M
- Investors: 15
- Date of first sale: 2020-05-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-367717

## Issuer

- Name: BCD Bioscience, Inc.
- CIK: 0001813229
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2019
- Address: 231 G STREET, DAVIS, CA, 95616
- Phone: (530) 400-8155

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Carlito Lebrilla | Director | Davis, CA |
| Carlito Lebrilla | Promoter | Davis, CA |
| Steven Watkins | Director | Davis, CA |
| Steven Watkins | Executive Officer | Davis, CA |
| Steven Watkins | Promoter | Davis, CA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-03-11](https://search.stillhousedata.com/formd/0001813229-22-000002) | D | $13.0M | $11.6M |
| [2020-05-27](https://search.stillhousedata.com/formd/0001813229-20-000002) | D | $4.8M | $4.5M |

## More

- [CIK 1813229 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1813229&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001813229-20-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.